Research Roundup

SGLT2 inhibitors, NSAIDs, budesonide-formoterol reliever therapy and medication review in RACFs SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes A systematic review of 4 studies provides substantiveevidence supporting the use of SGLT2 inhibitors to prevent major kidney outcomes in people with type 2 diabetes. SGLT2 inhibitors reduced the risk